As discussed earlier, CD4+ T-cells expressing the inhibitory co-receptor CTLA4 are particularly abundant in cHL, frequently contact HRS cells, and are further enriched after PD-1 blockade [54]. Here, CTLA4 is linked to classic Hodgkin lymphoma.